Trials / Completed
CompletedNCT01109758
Effects of Fenofibrate on Gene Expression in Healthy Volunteers
Effects of Fenofibrate on Gene Expression Activity and DNA Methylation Profile in Circulating Monocytes of Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess how fenofibrate modify gene expression in circulating monocytes of healthy volunteers after 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate | 145 mg |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-07-01
- Completion
- 2008-08-01
- First posted
- 2010-04-23
- Last updated
- 2010-04-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01109758. Inclusion in this directory is not an endorsement.